Insights
Insights From Our Experts
Articles
Capital Efficient Commercialization: A New Model for Success
In today’s fiscal environment, efficient capital allocation is crucial for success. Biopharma companies can take advantage of new approaches to commercialization to dramatically reduce the capital burden to launch their products. Building Your Own Commercial Infrastructure…
Boosting Pharma Efficiency: A New Model for Asset Value Retention
In the pharmaceutical industry, maintaining asset value is challenging. Traditionally, companies either licensed their products or built their own commercial setup, each option with its own risks. But what if there were a powerful alternative that…
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such family’s journey underscores the importance of expert care, unwavering support and…
Maximizing Sales with AI: A Strategic Roadmap for Success
Artificial intelligence (AI) is transforming the sales landscape, offering innovative ways to boost efficiency, enhance decision-making and drive revenue growth. With AI adoption in sales ranking among the top three functions across industries, organizations must leverage…
Rare Disease Care in India: A Path to Positive Impact
Posted by
on March 19, 20253/19/25
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…
Enhancing Medical Strategies Through Effective Literature Surveillance
Posted by Mary Mehrabian, PharmD, BCGP, BCMAS , Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD on March 13, 20253/13/25
Members from EVERSANA’s Medical Affairs (MA) team conducted a comprehensive survey to understand the needs of MA professionals regarding literature surveillance, reviews and alerts. They presented their findings at the DIA Medical Affairs and Scientific Communications…
Revolutionizing Customer Experience: The Role of AI in Enhancing MI Contact Center Operations
Posted by Carolyn Quon, PharmD , Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD on March 13, 20253/13/25
At the 2025 DIA Medical Affairs and Scientific Communications Forum, experts from EVERSANA gave a presentation on the transformative role of AI in enhancing Medical Information (MI) Contact Center operations and its primary objective – to…
Trends Shaping Direct to Patient in Pharma
Direct-to-patient (DTP) models are being utilized more and more in recent years. While this provides pharma companies with new opportunities to reach patient populations, it also creates new complications that they need to find solutions for.…
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
Posted by Anne Marie Robertson , Barry Vucsko , Jordan Schell , Vanith Sankaran, PhD , Jordan Hayes on March 12, 20253/12/25
This article explores the significant advancements in CAR-T therapy and its transition from academic centers to community practices. CAR-T therapy, a revolutionary treatment for certain hematological malignancies, involves modifying a patient’s T-cells to target and destroy…
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
For pharmaceutical manufacturers, achieving optimal revenue in a competitive landscape is a multifaceted challenge that requires strategic foresight and meticulous execution. Small and emerging biotech companies often face significant hurdles in reaching maximum commercial success. In…